Cargando…

Alteronol Enhances the Anti-tumor Activity and Reduces the Toxicity of High-Dose Adriamycin in Breast Cancer

The first-line chemotherapy drug adriamycin (ADM) is widely used for the treatment of breast cancer, but the acquired drug resistance and the normal tissue toxicity remain clinical challenges. Alteronol has been reported to exert wide-ranging anti-tumor activity. In this study, we firstly examined t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Boxue, Ye, Lei, Gong, Jianwei, Ren, Huanhuan, Ding, Yangfang, Chen, Xiaoyu, Liu, Xiaona, Lu, Peng, Wei, Fei, Xu, Wenjuan, Zheng, Qiusheng, Li, Defang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455060/ https://www.ncbi.nlm.nih.gov/pubmed/31001113 http://dx.doi.org/10.3389/fphar.2019.00285

Ejemplares similares

Chamaejasmin B Decreases Malignant Characteristics of Mouse Melanoma B16F0 and B16F10 Cells
por: Si, Lingling, et al.
Publicado: (2020)

Eriodictyol Attenuates Myocardial Ischemia-Reperfusion Injury through the Activation of JAK2
por: Li, Defang, et al.
Publicado: (2018)

Alternol/Alteronol: Potent Anti-cancer Compounds With Multiple Mechanistic Actions
por: Liu, Wang, et al.
Publicado: (2020)

Licochalcone D induces apoptosis and inhibits migration and invasion in human melanoma A375 cells
por: Si, Lingling, et al.
Publicado: (2018)

Autophagy inhibition potentiates the anti-EMT effects of alteronol through TGF-β/Smad3 signaling in melanoma cells
por: Bao, Yong, et al.
Publicado: (2020)

Astragaloside IV Attenuates the Myocardial Injury Caused by Adriamycin by Inhibiting Autophagy
por: Luo, Li-Fei, et al.
Publicado: (2021)

Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin
por: Wang, Yingying, et al.
Publicado: (2020)

Atractylenolide I Inhibits NLRP3 Inflammasome Activation in Colitis-Associated Colorectal Cancer via Suppressing Drp1-Mediated Mitochondrial Fission
por: Qin, Yao, et al.
Publicado: (2021)

Rosmarinic Acid Protects against Inflammation and Cardiomyocyte Apoptosis during Myocardial Ischemia/Reperfusion Injury by Activating Peroxisome Proliferator-Activated Receptor Gamma
por: Han, Jichun, et al.
Publicado: (2017)

Empagliflozin Ameliorates Preeclampsia and Reduces Postpartum Susceptibility to Adriamycin in a Mouse Model Induced by Angiotensin Receptor Agonistic Autoantibodies
por: Zhai, Ruonan, et al.
Publicado: (2022)

Therapeutic effects on cancer of the active ingredients in rhizoma paridis
por: Li, Jie, et al.
Publicado: (2023)

Neochamaejasmin A Induces Mitochondrial-Mediated Apoptosis in Human Hepatoma Cells via ROS-Dependent Activation of the ERK1/2/JNK Signaling Pathway
por: Ding, Yangfang, et al.
Publicado: (2020)

Licochalcone E protects against carbon tetrachloride-induced liver toxicity by activating peroxisome proliferator-activated receptor gamma
por: Han, Jichun, et al.
Publicado: (2017)

Therapeutic Potential of Astragaloside IV Against Adriamycin-Induced Renal Damage in Rats via Ferroptosis
por: Qin, Lu-Yun, et al.
Publicado: (2022)

Yi-Shen-Hua-Shi Granule Alleviates Adriamycin-Induced Glomerular Fibrosis by Suppressing the BMP2/Smad Signaling Pathway
por: Tan, Zhuojing, et al.
Publicado: (2022)

Icariin induces cell differentiation and cell cycle arrest in mouse melanoma B16 cells via Erk1/2-p38-JNK-dependent pathway
por: Wang, Dan, et al.
Publicado: (2017)

Coadministration of bedaquiline and pyrifazimine reduce exposure to toxic metabolite N-desmethyl bedaquiline
por: Ding, Yangming, et al.
Publicado: (2023)

Guideline Adherence of β-blocker Initiating Dose and its Consequence in Hospitalized Patients With Heart Failure With Reduced Ejection Fraction
por: Zhou, Yiling, et al.
Publicado: (2021)

Caffeine Modulates the Antitumor Activity and Toxic Side Effects of Adriamycin
por: Sadzuka, Yasuyuki, et al.
Publicado: (1993)

Metabolomics Reveals the Mechanisms for the Pulmonary Toxicity of Siegesbeckia orientalis L. and the Toxicity-Reducing Effect of Processing
por: Jiang, Ting, et al.
Publicado: (2021)

Differences in Multicomponent Pharmacokinetics, Tissue Distribution, and Excretion of Tripterygium Glycosides Tablets in Normal and Adriamycin–Induced Nephrotic Syndrome Rat Models and Correlations With Efficacy and Hepatotoxicity
por: Wu, Wei, et al.
Publicado: (2022)

Acute Induction of Adriamycin‐resistance in Human Colon Carcinoma HT‐29 Cells Exposed to a Sublethal Dose of Adriamycin
por: Tomida, Akihiro, et al.
Publicado: (1995)

A Fixed-Dose Combination, QXOH/Levobupivacaine, Produces Long-Acting Local Anesthesia in Rats Without Additional Toxicity
por: Yin, Qinqin, et al.
Publicado: (2019)

Yue-bi-tang attenuates adriamycin-induced nephropathy edema through decreasing renal microvascular permeability via inhibition of the Cav-1/ eNOS pathway
por: Li, Tingting, et al.
Publicado: (2023)

CYP2J2(∗)7 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients
por: Ahmed, Jemal Hussien, et al.
Publicado: (2019)

Furfural Produces Dose-Dependent Attenuating Effects on Ethanol-Induced Toxicity in the Liver
por: Cheng, Zhuo, et al.
Publicado: (2022)

Specific Reduction of Toxic Side Effects of Adriamycin by Induction of Metallothionein in Mice
por: Naganuma, Akira, et al.
Publicado: (1988)

Efficacy and Safety of Apatinib for the Treatment of Advanced or Recurrent Cervical Cancer: A Single-Arm Meta-Analysis Among Chinese Patients
por: Huang, Da, et al.
Publicado: (2022)

Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parameters.
por: Johnson, P. J., et al.
Publicado: (1992)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Astragalin Promotes Osteoblastic Differentiation in MC3T3-E1 Cells and Bone Formation in vivo
por: Liu, Li, et al.
Publicado: (2019)

Total Extracts of Abelmoschus manihot L. Attenuates Adriamycin-Induced Renal Tubule Injury via Suppression of ROS-ERK1/2-Mediated NLRP3 Inflammasome Activation
por: Li, Wei, et al.
Publicado: (2019)

Novel Sigma-2 receptor ligand A011 overcomes MDR in adriamycin-resistant human breast cancer cells by modulating ABCB1 and ABCG2 transporter function
por: Zeng, Zhanwei, et al.
Publicado: (2022)

Protective Effects of Kaempferol against Myocardial Ischemia/Reperfusion Injury in Isolated Rat Heart via Antioxidant Activity and Inhibition of Glycogen Synthase Kinase-3β
por: Zhou, Mingjie, et al.
Publicado: (2015)

Association of NQO2 With UDP-Glucuronosyltransferases Reduces Menadione Toxicity in Neuroblastoma Cells
por: Chhour, Monivan, et al.
Publicado: (2021)

Intracranial Hemorrhage Following Oral Low-Dose Methotrexate After Multiple Toxicities Caused by High-Dose Methotrexate in Childhood Acute Lymphoblastic Leukemia
por: Xin, Ning, et al.
Publicado: (2019)

Gut Microbiota Combined With Metabolomics Reveals the Repeated Dose Oral Toxicity of β-Cyclodextrin in Mice
por: Lv, Shuangyu, et al.
Publicado: (2021)

Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia
por: Wu, Angela, et al.
Publicado: (2023)

Successful treatment discontinuation in CML patients with full-dose and low-dose TKI: Results from real-world practice
por: Chen, Yilin, et al.
Publicado: (2023)

Rubidazone vs adriamycin: an evaluation of their differential toxicity in the spleen colony assay system.
por: Alberts, D. S., et al.
Publicado: (1976)

Cannot write session to /tmp/vufind_sessions/sess_hk3g41kru9t5ijcin8gde6gh73